Samlyn Capital’s Encompass Health EHC Stock Holding History

Samlyn Capital’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-389,863	Closed	-$26.2M	–	95
2023 Q3	$26.2M	Buy	+389,863	New	+$26.8M	0.43%	69

Other funds holding EHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Samlyn Capital's EHC Position: Q4 2023 in Review

Samlyn Capital sold out of Encompass Health (EHC) in Q4 2023, closing a stake of 389,863 shares — an estimated $26.2M sold.

Samlyn Capital first reported a position in EHC in Q3 2023 and held it in 1 quarter. The position peaked at $26.2M in Q3 2023. 435 funds tracked by Wall St. Rank hold EHC as of Q4 2023.

Samlyn Capital reported no remaining Encompass Health position as of Q4 2023 after selling out during the quarter.
Samlyn Capital sold 389,863 Encompass Health shares in Q4 2023, an estimated $26.2M.
Samlyn Capital first reported a position in Encompass Health in Q3 2023 and held it in 1 quarter.
Samlyn Capital's Encompass Health position peaked at $26.2M in Q3 2023.
435 funds tracked by Wall St. Rank held Encompass Health as of Q4 2023.

Based on Samlyn Capital's 13F filing for Q4 2023, filed 14 Feb 2024.